Opicapone is a potent, reversible, and peripherally-acting third-generation inhibitor of catechol-o-methyltransferase (COMT), an enzyme involved in the breakdown of various catecholamines including dopamine. Many patients with Parkinson’s disease treated with levodopa plus a dopa decarboxylase (DDC) inhibitor (eg carbidopa) experience motor complications over time, which calls for the management of these symptoms through the use of a dopamine agonist, a monoamine oxidase B inhibitor (selegiline, rasagiline), a catechol-O-methyl transferase (COMT) inhibitor, or amantadine, or using a modified-release formulation of levodopa. It is grouped under the following drug class(es): Dopamine agents and Neurotransmitter agents. Its therapeutic use is listed as antiparkinsonian agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include ongentys, Ontilyv, 1, 2-Benzenediol, 5-(3-(2, 5-dichloro-4, 6-dimethyl-1-oxido-3-pyridinyl)-1, 2 and 4-oxadiazol-5-yl)-3-nitro-. Its PubChem CID is 135565903.
Opicapone
| CAS No | 923287-50-7 |
|---|---|
| Molecular Formula | C15H10Cl2N4O6 |
| Molecular Weight | 413.2 g/mol |
| Synonyms | 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-1,2,4-oxadiazol-5-yl]-3-nitrobenzene-1,2-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Opicapone is a potent, reversible, and peripherally-acting third-generation inhibitor of catechol-o-methyltransferase (COMT), an enzyme involved in the breakdown of various catecholamines including dopamine.
The listed CAS number is 923287-50-7.
The listed molecular formula is C15H10Cl2N4O6.
The listed molecular weight is 413.2 g/mol.
5-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-1,2,4-oxadiazol-5-yl]-3-nitrobenzene-1,2-diol.
The source lists ongentys, Ontilyv, 1, 2-Benzenediol, 5-(3-(2, 5-dichloro-4, 6-dimethyl-1-oxido-3-pyridinyl)-1, 2 and 4-oxadiazol-5-yl)-3-nitro-.